DOC vs NEU

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

DOC

DOCTORCARE CDI 1:1 [DOC]

55MEDIUM

NEU

NEUREN FPO NZ [NEU]

55MEDIUM

Score Breakdown

DOC NEU
Technical
50
69
Catalyst
53
51
Sentiment
50
50
Fundamental
92
78
Momentum
58
59
Risk Gate
45
43

Key Metrics

DOC Metric NEU
$47.7MMarket Cap$2.6B
53KAvg Volume (20d)610K
N/AShort Interest+4.0%
$0.21052-Week High$23.760
$0.10552-Week Low$11.000
-3.8%Daily Change+3.1%
$0.125Reference Price$20.570
+147.4%ROE+6.2%
+3.3%Profit Margin+29.1%

Active Signals

DOC Signals

●Stochastic turning bearish from a high level — caution
●Trading above both moving averages — the trend is your friend here
●Beating the Small Ords index — relative strength of 1.22, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+6%)
●Piotroski F-Score strong (9/9, low-confidence approx)

NEU Signals

●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate revenue growth (+17%)
●Piotroski F-Score strong (7/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Post-earnings drift: negative surprise (SUE -10)

Ask Scout AI to compare DOC and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

DOC vs SOM →ARX vs CMP →ARX vs PIQ →ATX vs CMP →ATX vs EPI →
DOC Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).